Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News and Analysis
  • Published:

European Lead Factory hits its stride

An Erratum to this article was published on 01 June 2016

An Erratum to this article was published on 06 April 2016

This article has been updated

A large European drug discovery consortium is making inroads into novel chemical and biological space.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Change history

  • 06 April 2016

    In the version of this article originally published, the name Ton Rijnders was misspelt, and the number of options notices that have been triggered was incorrectly reported. These errors have been corrected in the online and PDF versions of the article.

  • 01 June 2016

    In the version of the article originally published, Merck & Co. was incorrectly listed as one of the pharmaceutical partners of the European Lead Factory, instead of Merck KGaA. This error has been corrected in the online versions of the article.

Authors

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kingwell, K. European Lead Factory hits its stride. Nat Rev Drug Discov 15, 221–222 (2016). https://doi.org/10.1038/nrd.2016.64

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd.2016.64

This article is cited by

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research